Works matching DE "PROGRAMMED death-ligand 1"

Results: 3444

Selective Degradation of PD‐L1 in Cancer Cells by Enzyme‐Instructed Self‐Assembly.

Published in:

2023

By:

Wang, Yuhan;
Li, Xinxin;
Zheng, Debin;
Chen, Yumiao;
Zhang, Zhenghao;
Yang*, Zhimou

Publication type:

Correction Notice

A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic Immunotherapy.

Published in:

Advanced Functional Materials, 2023, v. 33, n. 16, p. 1, doi. 10.1002/adfm.202214499

By:

Wang, He;
Gao, Zhiyuan;
Jiao, Di;
Zhang, Yufan;
Zhang, Jingtian;
Wang, Tianjiao;
Huang, Yuhua;
Zheng, Donghui;
Hou, Jianquan;
Ding, Dan;
Zhang, Weijie

Publication type:

Article

Less is More: Preorganization Leads to Better Tumor Retention and Therapeutic Efficacy.

Published in:

Advanced Functional Materials, 2022, v. 32, n. 49, p. 1, doi. 10.1002/adfm.202206969

By:

Xie, Limin;
Ding, Yinghao;
Wang, Yuhan;
Li, Xinxin;
Yang, Zhimou;
Hu, Zhi‐Wen

Publication type:

Article

A Versatile 980 nm Absorbing Aggregation‐Induced Emission Luminogen for NIR‐II Imaging‐Guided Synergistic Photo‐Immunotherapy Against Advanced Pancreatic Cancer.

Published in:

Advanced Functional Materials, 2022, v. 32, n. 36, p. 1, doi. 10.1002/adfm.202205371

By:

Wang, Miao;
Yan, Dingyuan;
Wang, Meng;
Wu, Qian;
Song, Ruixiang;
Huang, Yiming;
Rao, Jie;
Wang, Dong;
Zhou, Feifan;
Tang, Ben Zhong

Publication type:

Article

Inosine‐Based Supramolecular Hydrogel for Highly Efficient PD‐L1 Blockade Therapy via Mediating CD8+ T Cells (Adv. Funct. Mater. 33/2022).

Published in:

Advanced Functional Materials, 2022, v. 32, n. 33, p. 1, doi. 10.1002/adfm.202204273

By:

Qi, Jiajia;
Ding, Tingting;
Liu, Tiannan;
Xia, Xin;
Wu, Shihong;
Liu, Jiang;
Chen, Qianming;
Zhang, Dunfang;
Zhao, Hang

Publication type:

Article

Inosine‐Based Supramolecular Hydrogel for Highly Efficient PD‐L1 Blockade Therapy via Mediating CD8+ T Cells.

Published in:

Advanced Functional Materials, 2022, v. 32, n. 33, p. 1, doi. 10.1002/adfm.202204273

By:

Qi, Jiajia;
Ding, Tingting;
Liu, Tiannan;
Xia, Xin;
Wu, Shihong;
Liu, Jiang;
Chen, Qianming;
Zhang, Dunfang;
Zhao, Hang

Publication type:

Article

Boosting Tumor Immunotherapy by Bioactive Nanoparticles via Ca2+ Interference Mediated TME Reprogramming and Specific PD‐L1 Depletion.

Published in:

Advanced Functional Materials, 2022, v. 32, n. 24, p. 1, doi. 10.1002/adfm.202201275

By:

An, Jingyi;
Liu, Mengyuan;
Zhao, Ling;
Lu, Wenxin;
Wu, Sixuan;
Zhang, Kaixiang;
Liu, Junjie;
Zhang, Zhenzhong;
Shi, Jinjin

Publication type:

Article

Selective Degradation of PD‐L1 in Cancer Cells by Enzyme‐Instructed Self‐Assembly.

Published in:

Advanced Functional Materials, 2021, v. 31, n. 45, p. 1, doi. 10.1002/adfm.202102505

By:

Wang, Yuhan;
Li, Xinxin;
Zheng, Debin;
Chen, Yumiao;
Zhang, Zhenghao;
Yang, Zhimou

Publication type:

Article

Inspired Epigenetic Modulation Synergy with Adenosine Inhibition Elicits Pyroptosis and Potentiates Cancer Immunotherapy.

Published in:

Advanced Functional Materials, 2021, v. 31, n. 20, p. 1, doi. 10.1002/adfm.202100007

By:

Xiong, Honggang;
Ma, Xianbin;
Wang, Xiaolong;
Su, Wen;
Wu, Lei;
Zhang, Tian;
Xu, Zhigang;
Sun, Zhi‐Jun

Publication type:

Article

Implantable Bioresponsive Nanoarray Enhances Postsurgical Immunotherapy by Activating Pyroptosis and Remodeling Tumor Microenvironment.

Published in:

Advanced Functional Materials, 2020, v. 30, n. 51, p. 1, doi. 10.1002/adfm.202005747

By:

Zhao, Hongjuan;
Song, Qingling;
Zheng, Cuixia;
Zhao, Beibei;
Wu, Lixia;
Feng, Qianhua;
Zhang, Zhenzhong;
Wang, Lei

Publication type:

Article

Near‐Infrared Triggered Cascade of Antitumor Immune Responses Based on the Integrated Core–Shell Nanoparticle.

Published in:

Advanced Functional Materials, 2020, v. 30, n. 50, p. 1, doi. 10.1002/adfm.202000335

By:

Cheng, Qian;
Gao, Fan;
Yu, Wu‐Yang;
Zou, Mei‐Zhen;
Ding, Xing‐Lan;
Li, Min‐Jie;
Cheng, Si‐Xue;
Zhang, Xian‐Zheng

Publication type:

Article

Characterization of PD-L1 binding sites by a combined FMO/GRID-DRY approach.

Published in:

Journal of Computer-Aided Molecular Design, 2020, v. 34, n. 8, p. 897, doi. 10.1007/s10822-020-00306-0

By:

Paciotti, Roberto;
Agamennone, Mariangela;
Coletti, Cecilia;
Storchi, Loriano

Publication type:

Article

The roles of PD-L1 in the various stages of tumor metastasis.

Published in:

Cancer & Metastasis Reviews, 2024, v. 43, n. 4, p. 1475, doi. 10.1007/s10555-024-10189-4

By:

He, Yinjun;
Zhu, Ming;
Lai, Xuan;
Zhang, Honghe;
Jiang, Weiqin

Publication type:

Article

Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma.

Published in:

Cancer & Metastasis Reviews, 2024, v. 43, n. 3, p. 889, doi. 10.1007/s10555-024-10174-x

By:

Roozitalab, Ghazaal;
Abedi, Behnaz;
Imani, Saber;
Farghadani, Reyhaneh;
Jabbarzadeh Kaboli, Parham

Publication type:

Article

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer.

Published in:

Cancer & Metastasis Reviews, 2021, v. 40, n. 2, p. 537, doi. 10.1007/s10555-021-09972-4

By:

Heeke, Arielle L.;
Tan, Antoinette R.

Publication type:

Article

PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.

Published in:

World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-024-05392-5

By:

de Jong, Florus C.;
Kvikstad, Vebjørn;
Hoedemaeker, Robert F.;
van der Made, Angelique C. J.;
van der Bosch, Thierry P.;
van Casteren, Niels J.;
van Kessel, Kim E. M.;
Zwarthoff, Ellen C.;
Boormans, Joost L.;
Zuiverloon, Tahlita C. M.

Publication type:

Article

Racial/ethnic differences in survival and treatment response with PD-1/PD-L1 inhibitors in resectable non-small cell lung cancer: a meta-analysis of randomized controlled trials.

Published in:

European Journal of Clinical Pharmacology, 2025, v. 81, n. 1, p. 139, doi. 10.1007/s00228-024-03777-4

By:

de Moraes, Francisco Cezar Aquino;
Pasqualotto, Eric;
de Oliveira Rodrigues, Anna Luíza Soares;
Burbano, Rommel Mario Rodríguez

Publication type:

Article

The sound and surprise: overlapping meta-analyses on the topic of safety and efficacy of PD-1 and PD-L1 inhibitors in the treatment of non-small cell lung cancer.

Published in:

European Journal of Clinical Pharmacology, 2023, v. 79, n. 12, p. 1665, doi. 10.1007/s00228-023-03577-2

By:

Ou, Shun-Long;
Luo, Jing;
Wang, Song;
Li, Kai-Yue;
Du, Su-Ya;
Jiang, Qian

Publication type:

Article

Possibility of PD-1/PD-L1 Inhibitors for the Treatment of Patients with Chronic Hepatitis B Infection.

Published in:

Digestive Diseases, 2024, v. 42, n. 1, p. 53, doi. 10.1159/000534535

By:

Su, Menghan;
Ye, Ting;
Wu, Wei;
Shu, Zheyue;
Xia, Qi

Publication type:

Article

A Rare Case of NUT Carcinoma of the Thyroid.

Published in:

JCEM Case Reports, 2024, v. 2, n. 3, p. 1, doi. 10.1210/jcemcr/luae037

By:

Cadesky, Adam;
Schulman-Rosenbaum, Rifka;
Carter, Amanda;
Paul, Elizabeth;
Jaggi, Shuchie

Publication type:

Article

Iatrogenic Pituitary Shutdown: A Rare Adverse Event of Programmed Cell Death-Ligand 1 Inhibitor.

Published in:

JCEM Case Reports, 2024, v. 2, n. 1, p. 1, doi. 10.1210/jcemcr/luad157

By:

Al-Hiari, Mohammed;
Workman, Anthony;
Ezeh, Ebubechukwu;
Teka, Samson

Publication type:

Article

Redefining Treatment Paradigms in Metastatic Castration-resistant Prostate Cancer: A Comprehensive Analysis of Cabozantinib and Atezolizumab Based on the CONTACT-02 Study Results.

Published in:

touchREVIEWS in Oncology & Haematology, 2024, v. 20, n. 2, p. 45, doi. 10.17925/OHR.2024.20.2.3

By:

Elyas, Sara;
Vaishampayan, Ulka

Publication type:

Article

Durvalumab: A PD-L1 Blocking Antibody for the Treatment of Adult Patients with Locally Advanced or Metastatic Biliary Tract Cancer.

Published in:

touchREVIEWS in Oncology & Haematology, 2023, v. 19, n. 1, p. 22, doi. 10.17925/OHR.2023.19.1.22

By:

Mahipal, Amit;
Palmer, Mathias;
Gile, Jennifer;
Kim, Richard

Publication type:

Article

Coffee extracts and caffeine upregulate the expression of the immune checkpoint factors, PD‑1 and PD‑L1.

Published in:

International Journal of Functional Nutrition, 2024, v. 5, n. 1, p. N.PAG, doi. 10.3892/ijfn.2024.36

By:

Yoshida, Tatsushi;
Yamasaki, Kenta;
Horinaka, Mano;
Tadagaki, Kenjiro

Publication type:

Article

Weakly supervised deep learning to predict recurrence in low-grade endometrial cancer from multiplexed immunofluorescence images.

Published in:

NPJ Digital Medicine, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s41746-023-00795-x

By:

Jiménez-Sánchez, Daniel;
López-Janeiro, Álvaro;
Villalba-Esparza, María;
Ariz, Mikel;
Kadioglu, Ece;
Masetto, Ivan;
Goubert, Virginie;
Lozano, Maria D.;
Melero, Ignacio;
Hardisson, David;
Ortiz-de-Solórzano, Carlos;
de Andrea, Carlos E.

Publication type:

Article

A retrospective study on immune-related pneumonitis in patients with non-small-cell lung cancer undergoing treatment with PD-1/PD-L1 inhibitors.

Published in:

European Clinical Respiratory Journal, 2023, v. 10, p. 1, doi. 10.1080/20018525.2023.2194162

By:

Yakymenko, Dorthe;
Skougaard, Kristin

Publication type:

Article

The prevalence of tumour markers in malignant pleural effusions associated with primary pulmonary adenocarcinoma: a retrospective study.

Published in:

European Clinical Respiratory Journal, 2021, v. 8, n. 1, p. 1, doi. 10.1080/20018525.2021.1984375

By:

Fjaellegaard, Katrine;
Koefod Petersen, Jesper;
Andersen, Gitte;
Biagini, Matteo;
Bhatnagar, Rahul;
Laursen, Christian B.;
Clementsen, Paul Frost;
Bodtger, Uffe

Publication type:

Article

Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry.

Published in:

Turkish Journal of Medical Sciences, 2024, v. 54, n. 4, p. 735, doi. 10.55730/1300-0144.5843

By:

SAYGIN, İsmail;
ÇAKIR, Emel;
KAZAZ, Seher Nazlı;
GÜVERCİN, Ali Rıza;
EYÜPOĞLU, İlker;
USTAOĞLU, Müşerref Müge

Publication type:

Article

Role of PD-1/PD-L1-mediated tumour immune escape mechanism and microsatellite instability in the BCG failure of high-grade urothelial carcinomas.

Published in:

Turkish Journal of Medical Sciences, 2022, v. 52, n. 6, p. 1802, doi. 10.55730/1300-0144.5526

By:

SALMAN, Fadime Gül;
KANKAYA, Duygu;
ÖZAKINCI, Hilal;
ŞAHİN, Yasemin;
KUBİLAY, Eralp;
SÜER, Evren;
HAYME, Serhat;
BALTACI, Sümer

Publication type:

Article

The correlation of serum sPD-1 and sPD-L1 levels with clinical, pathological characteristics and lymph node metastasis in nonsmall cell lung cancer patients.

Published in:

Turkish Journal of Medical Sciences, 2022, v. 52, n. 4, p. 1050, doi. 10.55730/1300-0144.5407

By:

ANCIN, Burcu;
ÖZERCAN, Mesut Melih;
YILMAZ, Yiğit;
UYSAL, Serkan;
KUMBASAR, Ulaş;
SARIBAŞ, Zeynep;
DİKMEN, Erkan;
DOĞAN, Rıza;
DEMİRCİN, Metin

Publication type:

Article

PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis.

Published in:

Turkish Journal of Medical Sciences, 2022, v. 52, n. 4, p. 1013, doi. 10.55730/1300-0144.5403

By:

ÖZDEMİR, Süleyman;
TON, Özlem;
KABUKCUOĞLU, Fevziye

Publication type:

Article

The importance of histological patterns on PD-L1 staining heterogeneity: Should we use pattern-based approach for selecting tumor samples for PD-L1 testing in lung adenocarcinomas?

Published in:

Turkish Journal of Medical Sciences, 2021, v. 51, n. 1, p. 204, doi. 10.3906/sag-2004-61

By:

BULUTAY, Pınar;
FIRAT, Pınar;
ZEREN, Handan;
ERUS, Suat;
TANJU, Serhan;
DİLEGE, Şükrü

Publication type:

Article

The yeast also rises! PD-L1 dampens inflammation linked to fungal infections.

Published in:

Science Immunology, 2024, v. 9, n. 98, p. N.PAG, doi. 10.1126/sciimmunol.adr9663

By:

AlSalem, Sultan;
Pillai, Shiv

Publication type:

Article

Separation anxiety: Splitting PD-L1 from CD80 suppresses autoimmunity.

Published in:

2022

By:

Bracey, Nathan A.;
Maltzman, Jonathan S.

Publication type:

Abstract

Antigen cross-presentation in young tumor-bearing hosts promotes CD8+ T cell terminal differentiation.

Published in:

Science Immunology, 2022, v. 7, n. 68, p. 1, doi. 10.1126/sciimmunol.abf6136

By:

Moustaki, Ardiana;
Crawford, Jeremy Chase;
Alli, Shanta;
Fan, Yiping;
Boi, Shannon;
Zamora, Anthony E.;
McDonald, Natalie M. N.;
Wu, Gang;
Nakitandwe, Joy;
Newman, Scott;
Foy, Scott;
Silkov, Antonina;
Thomas, Paul G.;
Pappo, Alberto;
Dyer, Michael A.;
Stewart, Elizabeth;
Federico, Sara;
Youngblood, Ben

Publication type:

Article

Immunotheraphy for Breast Cancer by Immune Check Point Inhibitors (Pd-1 & Pd-L1) using CNN for Image Analysis in Deep Learning.

Published in:

Grenze International Journal of Engineering & Technology (GIJET), 2024, v. 10, n. 2,Part 4, p. 5745

By:

R., Abila;
P., Ranjith kumar.;
R., Reeta Ruby

Publication type:

Article

Real-World Biomarker Test Utilization and Subsequent Treatment in Patients with Early-Stage Non-small Cell Lung Cancer in the United States, 2011−2021.

Published in:

Oncology & Therapy, 2023, v. 11, n. 3, p. 343, doi. 10.1007/s40487-023-00234-7

By:

Yan, Jessie T.;
Jin, Yue;
Lo, Ernest;
Chen, Yilin;
Hanlon Newell, Amy E.;
Kong, Ying;
Inge, Landon J.

Publication type:

Article

Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.

Published in:

Oncology & Therapy, 2023, v. 11, n. 2, p. 185, doi. 10.1007/s40487-023-00226-7

By:

Zheng, Shuwen;
Feng, Yumei;
Li, Chan;
Zhang, Jie;
Xie, Ke

Publication type:

Article

PD-L1 testing and immunotherapy selection - early laboratory experience and its potential role in head and neck cancer management.

Published in:

Archive of Clinical Cases, 2021, v. 8, n. 1, p. 14, doi. 10.22551/2021.30.0801.10179

By:

Bancu, Andrei;
Cowan, Richard;
Chaturvedi, Anshuman

Publication type:

Article

Fighting disease at 83 years old: SARS-CoV-2 survival and response to anti-PD-1 therapy in PD-L1 negative adenocarcinoma of the lung – case report.

Published in:

Oncolog-Hematolog, 2022, n. 58, p. 32

By:

Nedelcu Rezumat (Chiurciu), Maria;
Dragomir, Adelina Silvana;
Mateianu, Elena Adriana;
Stănculeanu, Dana Lucia

Publication type:

Article

Neoadjuvant treatment in triple-negative breast cancer.

Published in:

Oncolog-Hematolog, 2020, n. 52, p. 40

By:

Galeş, Laurenţia;
Bacinschi, Xenia;
Trifănescu, Oana;
Şerbănescu, Luiza;
Anghel, Rodica

Publication type:

Article

A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.

Published in:

Vaccines, 2024, v. 12, n. 5, p. 474, doi. 10.3390/vaccines12050474

By:

Hsu, Ping-Chih;
Wu, Bing-Chen;
Wang, Chin-Chou;
Chiu, Li-Chung;
Chang, Chiung-Hsin;
Liu, Ping-Chi;
Wu, Chiao-En;
Kuo, Scott Chih-Hsi;
Ju, Jia-Shiuan;
Huang, Allen Chung-Cheng;
Lin, Yu-Ching;
Yang, Cheng-Ta;
Ko, How-Wen

Publication type:

Article

Usp22 Deficiency Leads to Downregulation of PD-L1 and Pathological Activation of CD8 + T Cells and Causes Immunopathology in Response to Acute LCMV Infection.

Published in:

Vaccines, 2023, v. 11, n. 10, p. 1563, doi. 10.3390/vaccines11101563

By:

Friebus-Kardash, Justa;
Christ, Theresa Charlotte;
Dietlein, Nikolaus;
Elwy, Abdelrahman;
Abdelrahman, Hossam;
Holnsteiner, Lisa;
Hu, Zhongwen;
Rodewald, Hans-Reimer;
Lang, Karl Sebastian

Publication type:

Article

PD-L1 Is Involved in the Development of Non-Hodgkin's Lymphoma by Mediating Circulating Lymphocyte Apoptosis.

Published in:

Vaccines, 2023, v. 11, n. 9, p. 1474, doi. 10.3390/vaccines11091474

By:

Saber, Manal Mohamed

Publication type:

Article

Enhancement of Vaccine-Induced T-Cell Responses by PD-L1 Blockade in Calves.

Published in:

Vaccines, 2023, v. 11, n. 3, p. 559, doi. 10.3390/vaccines11030559

By:

Okagawa, Tomohiro;
Konnai, Satoru;
Nakamura, Hayato;
Ganbaatar, Otgontuya;
Sajiki, Yamato;
Watari, Kei;
Noda, Haruka;
Honma, Mitsuru;
Kato, Yukinari;
Suzuki, Yasuhiko;
Maekawa, Naoya;
Murata, Shiro;
Ohashi, Kazuhiko

Publication type:

Article

A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice.

Published in:

Vaccines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/vaccines10071092

By:

Pan, Jiayi;
Zeng, Wuyi;
Jia, Jiangtao;
Shi, Yi;
Wang, Danni;
Dong, Jun;
Fang, Zixuan;
He, Jiashan;
Yang, Xinyu;
Zhang, Rong;
He, Menghua;
Huang, Maoping;
Fu, Bishi;
Zhong, Bei;
Liu, Hui

Publication type:

Article

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma.

Published in:

Vaccines, 2021, v. 9, n. 5, p. 422, doi. 10.3390/vaccines9050422

By:

Fiste, Oraianthi;
Ntanasis-Stathopoulos, Ioannis;
Gavriatopoulou, Maria;
Liontos, Michalis;
Koutsoukos, Konstantinos;
Dimopoulos, Meletios Athanasios;
Zagouri, Flora;
Chew, Valerie;
Tsilimigras, Diamantis I.

Publication type:

Article

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model.

Published in:

Vaccines, 2020, v. 8, n. 4, p. 703, doi. 10.3390/vaccines8040703

By:

Pan, Yi-Ru;
Wu, Chiao-En;
Chen, Ming-Huang;
Huang, Wen-Kuan;
Shih, Hsuan-Jen;
Lan, Keng-Li;
Yeh, Chun-Nan

Publication type:

Article

The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy.

Published in:

Vaccines, 2020, v. 8, n. 2, p. 203, doi. 10.3390/vaccines8020203

By:

Botticelli, Andrea;
Cirillo, Alessio;
Scagnoli, Simone;
Cerbelli, Bruna;
Strigari, Lidia;
Cortellini, Alessio;
Pizzuti, Laura;
Vici, Patrizia;
De Galitiis, Federica;
Di Pietro, Francesca Romana;
Cerbelli, Edoardo;
Ghidini, Michele;
D'Amati, Giulia;
Della Rocca, Carlo;
Mezi, Silvia;
Gelibter, Alain;
Giusti, Raffaele;
Cortesi, Enrico;
Ascierto, Paolo Antonio;
Nuti, Marianna

Publication type:

Article

CMTM4 和 PD-L1蛋白在胰腺癌组织中的表达及其与临床病理特征的关系.

Published in:

Progress in Modern Biomedicine, 2024, v. 24, n. 13, p. 2478, doi. 10.13241/j.cnki.pmb.2024.13.014

By:

杨珍芳;
刘慧;
郭志娟;
吉茹;
靳君华

Publication type:

Article